We next evaluated the anti-tumor activity of GBR 401 in a disseminated lymphoma model in which human Raji cells expressing high levels of CD19 were injected intravenously into SCID mice and GBR 401 administered as described in the “Materials and Methods”. The gene discussed is CD19; the disease is neoplasm.